May 24, 2024 | Past Events
Prof. Dr. Axel Hauschild, on behalf of Philogen, is giving a presentation about the Phase III PIVOTAL study on May 31st, entitled “Phase 3 study (PIVOTAL) of neoadjuvant intralesional Daromun versus immediate surgery in fully resectable melanoma with regional skin...May 24, 2024 | Past Events
Dr. Ettore Gilardoni (Head of Mass Spectrometry) will attend the 72nd ASMS conference in Anaheim (2-6 June 2024) and present a poster entitled: “Mass Spectrometry evaluation of glycosylation variants and SP2/0 Host Cell Proteins during downstream processes: the case...May 24, 2024 | Past Events
Dr. Andrea Galbiati is giving a presentation about Philochem’s FAP ligand platform on June 9th, entitled “Development of Multivalent OncoFAP Derivatives for the Tumor-Targeted Delivery of Theranostic Radionuclides”. Dr. Samuele Cazzamalli is presenting a poster about...May 24, 2024 | Past Events
Apr 3, 2024 | 2024, Investors, Past Events
Management will host a 1-hour live webcast and conference call on April 3, 2024 at 10:00 ET / 15:00 BST / 16:00 CET. The presentation will be followed by a Q&A session. Please follow the link here to register to the event or contact us...Dec 18, 2023 | Past Events
The Italian Midcap Conference provides an opportunity for investors to get a perspective of Philogen progresses and to meet CEO Dario Neri and CFO Laura Baldi through a series of one-on-one meetings.
Recent Comments